Cue Health Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Clint Sever
- Full Time Employees
- 726
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 4980 Carroll Canyon Road San Diego CA United States of America 92121
- IPO Date
- Sep 24, 2021
- CIK
- 0001628945
- Website
- cuehealth.com
- Similar Companies
- Business
- Cue Health Inc. Cue Health Inc. (HLTH) operates as a healthcare technology company that develops and markets connected diagnostic platforms for at-home and point-of-care use, including the Cue Health Monitoring System comprising the reusable Cue Reader, single-use Cue Cartridges for molecular tests such as COVID-19, influenza, RSV, strep throat, cholesterol, HbA1c, vitamin D, fertility, testosterone, and expanding menus for respiratory, sexual, cardiac, metabolic, women's, and men's health; the Cue Data and Innovation Layer for cloud-based analytics; Cue Virtual Care Delivery Apps encompassing the Cue Health App and Enterprise Dashboard for telehealth, e-prescriptions, and reporting; and Cue Ecosystem Integrations with electronic medical records, pharmacies, clinician networks, and laboratories. Founded in 2010 and headquartered in San Diego, California, the company targets individuals, healthcare providers, clinics, and institutions across the United States with lab-quality, molecular diagnostics integrated with mobile apps and virtual care, previously distributing through partners like Cardinal Health and BioReference Laboratories. In May 2024, Cue Health Inc. filed for Chapter 7 bankruptcy liquidation in the U.S. Bankruptcy Court for the District of Delaware, ceasing operations, terminating all employees including executive leadership, and appointing a trustee to liquidate assets for creditor repayment after failed efforts to secure financing or strategic transactions amid post-pandemic revenue declines and cost-cutting measures.
Verizon Business returns to HLTH 2024 to showcase how 5G innovation drives the future of healthcare
TeleVox Showcases Latest Patient Relationship Management Innovations at HLTH 2024
UniDoc Health to Attend HLTH 2024 as Part of S&P500 TelCo's Booth
Why Is Cue Health (HLTH) Stock Up 99% Today?
Why Is Cue Health (HLTH) Stock Down 40% Today?
Cue Health to Pursue Wind Down of the Business
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Cue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)
Cue Health to Announce First Quarter Financial Results
Cue Health Announces Strategic Actions to Position Company for Next Stage
3 Promising Penny Stocks You Can Pick Up for Less Than a Quarter
Cue Health, Inc. (HLTH) Q4 2023 Earnings Call Transcript
Cue Health Inc. (HLTH) Reports Q4 Loss, Tops Revenue Estimates
Cue Health Reports Fourth Quarter 2023 Financial Results
Cue Health Announces Appointment of Rishi Reddy to Board of Directors
Cue Health to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Cue Health Inc. (HLTH) Q3 2023 Earnings Call Transcript
Cue Health Reports Third Quarter 2023 Financial Results
Cue Health to Announce Third Quarter 2023 Financial Results
Concerned Stockholders of Cue Health Send Letter to Board